Aclaris Therapeutics (ACRS) EBITDA Margin (QoQ) (2017 - 2026)
Aclaris Therapeutics (ACRS) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Aclaris Therapeutics |
580.93 Mn |
580.93 Mn |
1.60 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
50,492.00 |
| Dec 31, 2025 |
-108,807.00 |
| Sep 30, 2025 |
42,606.00 |
| Jun 30, 2025 |
14,805.00 |
| Mar 31, 2025 |
3,820.00 |
| Dec 31, 2024 |
-89,773.00 |
| Sep 30, 2024 |
24,669.00 |
| Jun 30, 2024 |
31,646.00 |
| Mar 31, 2024 |
-71,456.00 |
| Dec 31, 2023 |
31,277.00 |
| Sep 30, 2023 |
130,714.00 |
| Jun 30, 2023 |
-53,013.00 |
| Mar 31, 2023 |
-74,333.00 |
| Dec 31, 2022 |
-24,347.00 |
| Sep 30, 2022 |
126,124.00 |
| Jun 30, 2022 |
-2,229.00 |
| Mar 31, 2022 |
18,938.00 |
| Dec 31, 2021 |
-27,026.00 |
| Sep 30, 2021 |
-26,563.00 |
| Jun 30, 2021 |
62,263.00 |
